New patent for Delcath Systems drug HEPZATO

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for HEPZATO
Annual Drug Patent Expirations for HEPZATO

Hepzato is a drug marketed by Delcath Systems Inc and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug.

This drug has nineteen patent family members in nine countries.

The generic ingredient in HEPZATO is melphalan hydrochloride. One supplier is listed for this compound. Additional details are available on the melphalan hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top